SciELO - Scientific Electronic Library Online

 
vol.32 issue3Incidence of hypokalemia in patients with febrile neutropenia receiving treatment with liposomal amphotericin BIncidence of adverse events to chemotherapy using two detection methods: characterization and associated health costs author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista de la OFIL

On-line version ISSN 1699-714XPrint version ISSN 1131-9429

Abstract

OROZCO-SOLANO, S  and  SILVA-CASTRO, MM. Implementation of Comprehensive Medication Management in Costa Rican patients with chronic kidney disease. Rev. OFIL·ILAPHAR [online]. 2022, vol.32, n.3, pp.267-274.  Epub Sep 25, 2023. ISSN 1699-714X.  https://dx.doi.org/10.4321/s1699-714x20220003000010.

Objective:

Determine implementation results of the Comprehensive Medication Management (CMM) offered to patients with chronic kidney disease (CKD) who attended the Hospital Nephrology Service in Costa Rica.

Methods:

Mixed quantitative-qualitative, observative, descriptive and prospective study, in patients attending the Hospital Pharmaceutical Care Department through the CMM process, analysis of intermediate and preliminary results of health-related quality of life HRQOL using EQ 5D -5L.

Results:

Based on pilot study, 11 patients attended the first visit and 9 patients attended the third one. As result, 45 clinical conditions were analyzed, 1 of them was resolved, 20 were stable and 10 were improved. Total of 62 drug-therapy problems (DTP) were identified, with average of 5.6/patient. On regards to HRQOL, feedback obtained from kidney transplant patients indicated a better evaluation (mobility, personal care, daily activities, pain / discomfort), compared to CKD stage 5 5D dialysis patients (mobility impairment improvement). Utility measure reflected a change of 0.64±0.12 to 0.72±0.12, the health self-perception EQ VAS 68.18±23.58, to 87.22±8.53; and in terms of qualityadjusted life-year QALY, it showed a difference of 2.54±2.99.

Conclusions:

CMM implementation established in most health conditions improve or maintain patient stability. HRQOL was better for transplant patients compared to CKD 5D patients. Parameters such as utility, QALY, and EQ VAS were increased.

Keywords : Medication Therapy Management; patient-centered care; Patient Preference (MeSH); health-related quality of life (HRQOL); renal insufficiency chronic.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )